{"name":"Padagis LLC","slug":"padagis-llc","ticker":"","exchange":"","domain":"padagis.co.il","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":6,"colorKey":"oncology","drugs":[{"name":"Ingenol Mebutate (Reference)","genericName":"Ingenol Mebutate (Reference)","slug":"ingenol-mebutate-reference","indication":"Actinic keratosis (field treatment on face or scalp)","status":"phase_3"},{"name":"Zoryve","genericName":"Zoryve","slug":"zoryve","indication":"Other","status":"marketed"},{"name":"Adapalene and Benzoyl Peroxide Gel","genericName":"Adapalene and Benzoyl Peroxide Gel","slug":"adapalene-and-benzoyl-peroxide-gel","indication":"Other","status":"marketed"},{"name":"Ingenol Mebutate (Perrigo)","genericName":"Ingenol Mebutate (Perrigo)","slug":"ingenol-mebutate-perrigo","indication":"Actinic keratosis (field treatment on face, scalp, or trunk)","status":"phase_3"},{"name":"Ivermectin (reference)","genericName":"Ivermectin (reference)","slug":"ivermectin-reference","indication":"Onchocerciasis (river blindness)","status":"phase_3"},{"name":"Uceris","genericName":"Uceris","slug":"uceris","indication":"Other","status":"marketed"}]},{"name":"Dermatology","slug":"dermatology","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"neuroscience","drugs":[{"name":"Acanya Gel","genericName":"Acanya Gel","slug":"acanya-gel","indication":"Acne vulgaris","status":"phase_3"},{"name":"Azelaic acid foam","genericName":"Azelaic acid foam","slug":"azelaic-acid-foam","indication":"Rosacea","status":"phase_3"},{"name":"Epiduo Topical Product","genericName":"Epiduo Topical Product","slug":"epiduo-topical-product","indication":"Acne vulgaris","status":"phase_3"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"Acyclovir 5 percent (Perrigo)","genericName":"Acyclovir 5 percent (Perrigo)","slug":"acyclovir-5-percent-perrigo","indication":"Herpes simplex virus infection (topical)","status":"phase_3"},{"name":"Loprox Cream 0.77%","genericName":"Loprox Cream 0.77%","slug":"loprox-cream-0-77","indication":"Tinea pedis (athlete's foot)","status":"phase_3"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"cardiovascular","drugs":[{"name":"Azopt 1% Ophthalmic Suspension","genericName":"Azopt 1% Ophthalmic Suspension","slug":"azopt-1-ophthalmic-suspension","indication":"Elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma","status":"phase_3"},{"name":"Brinzolamide/brimonidine ophthalmic suspension","genericName":"Brinzolamide/brimonidine ophthalmic suspension","slug":"brinzolamide-brimonidine-ophthalmic-suspension","indication":"Open-angle glaucoma","status":"phase_3"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"infectious","drugs":[{"name":"Betamethasone Dipropionate 0.05% Cream","genericName":"Betamethasone Dipropionate 0.05% Cream","slug":"betamethasone-dipropionate-0-05-cream","indication":"Seborrheic dermatitis","status":"phase_2"}]}],"pipeline":[{"name":"Ingenol Mebutate (Reference)","genericName":"Ingenol Mebutate (Reference)","slug":"ingenol-mebutate-reference","phase":"phase_3","mechanism":"Ingenol mebutate is a protein kinase C (PKC) activator that induces rapid necrosis of treated cells and promotes immune-mediated clearance of actinic keratosis lesions.","indications":["Actinic keratosis (field treatment on face or scalp)"],"catalyst":""},{"name":"Acyclovir 5 percent (Perrigo)","genericName":"Acyclovir 5 percent (Perrigo)","slug":"acyclovir-5-percent-perrigo","phase":"phase_3","mechanism":"Acyclovir is a nucleoside analog that inhibits viral DNA polymerase, preventing herpes simplex virus and varicella-zoster virus from replicating.","indications":["Herpes simplex virus infection (topical)","Varicella-zoster virus infection (topical)"],"catalyst":""},{"name":"Azopt 1% Ophthalmic Suspension","genericName":"Azopt 1% Ophthalmic Suspension","slug":"azopt-1-ophthalmic-suspension","phase":"phase_3","mechanism":"Azopt is a carbonic anhydrase inhibitor that reduces aqueous humor production in the eye to lower intraocular pressure.","indications":["Elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma"],"catalyst":""},{"name":"Zoryve","genericName":"Zoryve","slug":"zoryve","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Acanya Gel","genericName":"Acanya Gel","slug":"acanya-gel","phase":"phase_3","mechanism":"Acanya Gel combines clindamycin (an antibiotic) and benzoyl peroxide (an antimicrobial oxidizing agent) to reduce acne-causing bacteria and decrease sebum production.","indications":["Acne vulgaris"],"catalyst":""},{"name":"Adapalene and Benzoyl Peroxide Gel","genericName":"Adapalene and Benzoyl Peroxide Gel","slug":"adapalene-and-benzoyl-peroxide-gel","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Azelaic acid foam","genericName":"Azelaic acid foam","slug":"azelaic-acid-foam","phase":"phase_3","mechanism":"Azelaic acid reduces inflammation and bacterial growth in the skin by inhibiting mitochondrial enzymes and reducing reactive oxygen species production.","indications":["Rosacea","Acne vulgaris","Post-inflammatory hyperpigmentation"],"catalyst":""},{"name":"Betamethasone Dipropionate 0.05% Cream","genericName":"Betamethasone Dipropionate 0.05% Cream","slug":"betamethasone-dipropionate-0-05-cream","phase":"phase_2","mechanism":"Betamethasone dipropionate is a corticosteroid that reduces inflammation and suppresses the immune system.","indications":["Seborrheic dermatitis","Psoriasis"],"catalyst":""},{"name":"Brinzolamide/brimonidine ophthalmic suspension","genericName":"Brinzolamide/brimonidine ophthalmic suspension","slug":"brinzolamide-brimonidine-ophthalmic-suspension","phase":"phase_3","mechanism":"Brinzolamide reduces aqueous humor production via carbonic anhydrase inhibition, while brimonidine decreases aqueous humor production and increases uveoscleral outflow via alpha-2 adrenergic receptor agonism, together lowering intraocular pressure.","indications":["Open-angle glaucoma","Ocular hypertension"],"catalyst":""},{"name":"Epiduo Topical Product","genericName":"Epiduo Topical Product","slug":"epiduo-topical-product","phase":"phase_3","mechanism":"Epiduo combines adapalene (a retinoid) and benzoyl peroxide to reduce acne by normalizing skin cell turnover and killing acne-causing bacteria.","indications":["Acne vulgaris"],"catalyst":""},{"name":"Ingenol Mebutate (Perrigo)","genericName":"Ingenol Mebutate (Perrigo)","slug":"ingenol-mebutate-perrigo","phase":"phase_3","mechanism":"Ingenol mebutate is a protein kinase C (PKC) activator that induces rapid necrosis of actinic keratosis cells and promotes immune-mediated clearance of precancerous lesions.","indications":["Actinic keratosis (field treatment on face, scalp, or trunk)"],"catalyst":""},{"name":"Ivermectin (reference)","genericName":"Ivermectin (reference)","slug":"ivermectin-reference","phase":"phase_3","mechanism":"Ivermectin binds to glutamate-gated chloride channels in parasitic organisms, causing paralysis and death of the parasite.","indications":["Onchocerciasis (river blindness)","Lymphatic filariasis","Strongyloidiasis","Scabies","Lice infestations"],"catalyst":""},{"name":"Loprox Cream 0.77%","genericName":"Loprox Cream 0.77%","slug":"loprox-cream-0-77","phase":"phase_3","mechanism":"Ciclopirox olamine disrupts fungal cell membrane and mitochondrial function by chelating polyvalent cations, leading to fungal cell death.","indications":["Tinea pedis (athlete's foot)","Tinea corporis (ringworm)","Tinea cruris (jock itch)","Candidiasis (cutaneous yeast infections)","Pityriasis versicolor"],"catalyst":""},{"name":"Uceris","genericName":"Uceris","slug":"uceris","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxOR2ZPeGlDZ3AydHFQcVNwaEV0QTBhTGNXaUYteHIwMlJWNXNlSzdibFFjWnRGbmY1TVFyR1FYMHRMQXE1d1JlMWs4QkxaQUtoSy1sUFdZT1pFeXg2ZVJrYVBXMUJJX0N1UHlOU0hNakFXYlo0d05SbnJHUVNCRkhNbUo2VHJlREg2Zm1FUHRfbGd2cTlYNThuUmkwa0JOSmlhUHk4NFo2SWUxa1NraUdqOEs1VGY4TE1kbHZISmk3d1N1MmJJ?oc=5","date":"2025-10-28","type":"pipeline","source":"prnewswire.com","summary":"Padagis Invests More Than $36 Million to Expand Manufacturing in the U.S. - prnewswire.com","headline":"Padagis Invests More Than $36 Million to Expand Manufacturing in the U.S.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxOc3EyYi1hcHZHZzNvQzlrQ0hWR2xwck8taExOeEpxWWVsc1FRYVlac0tNcWhaRUl6aFZNb2ROMWxHTDJXVEdhYXo4UTBBc1kxVWotaE9wbWsyR1RIMUx4RVA5NlVaMnMwMzAyTlhnLV9FZnFXY25LMUdaU05RUG5SUDVwS1BZcDRzbEdtSDFJdGdleXhkZC1KWUhHVXpRTVpjTlROc01ocUlvRjVIZTcwVVZ5bWZLV1BPamN6czdRdWxVaTJDd2E4Zg?oc=5","date":"2023-11-11","type":"patent","source":"Powder & Bulk Solids","summary":"Perrigo Closes $1.5B Sale of Generic Prescription Drugs Business - Powder & Bulk Solids","headline":"Perrigo Closes $1.5B Sale of Generic Prescription Drugs Business - Powder & Bulk Solids","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxOSXNTSVdPbllvWm1BODVBdjZvcDMxc0RWcVE4aDJCMHpJYklJVWpIbmpfTGhsTmV4cTlJMC15LVZlWWRRQUcyY1MxLUIzdG5GeE1fSUk1b05TS1U2VnJmSXlvM2JaY2paTUNWZ3JjSWkxaHlXRXVWNnJ5SlUtMnRQWFRjTWo1Q09EcGxxUms0SmRmamxuMzBiZXRzSDMzRW1yd3A4ZjNwd0dyUUhPMFV4LXhpOE1Kc3lJbGllMnAyQUl3U2VPQVd3M015VXZNMk40b1I3bXRnR1REalE?oc=5","date":"2023-10-13","type":"pipeline","source":"prnewswire.com","summary":"PADAGIS ANNOUNCES THE LAUNCH OF BRINZOLAMIDE OPHTHALMIC SUSPENSION WITH CGT EXCLUSIVITY - prnewswire.com","headline":"PADAGIS ANNOUNCES THE LAUNCH OF BRINZOLAMIDE OPHTHALMIC SUSPENSION WITH CGT EXCLUSIVITY","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxNeVhUNjhZWnJfRHMwZTdMQ1dIbnI2UzZieGxSbDlZVWRrMWx1MTV1SmlVNGpCN2JPZ3ozeERNelNyVG14RDNlSXhwRXFOMnVITlB4VzBzVURhQkdPR2R5MVlQdE5obldyN00yVHBUakFnY1gtSXFoTGFGVTRCbjJXdVQwNDJOQlZ4TzE3N0lBWTZzcU9YelJadjhoSktWeFRiZTgtVjN2ckhkV2c1MTlmb2ZjWlE2Q25HYm5vaVpURG9kWVVlQnByS256dU55WHJOYWhBMnBPdkozY2I5Mk1vVGFIWXNiNGJkQUlJ?oc=5","date":"2023-08-08","type":"pipeline","source":"prnewswire.com","summary":"PADAGIS ANNOUNCES THE FIRST LAUNCH OF AN OVER-THE-COUNTER NALOXONE NASAL SPRAY IN THE UNITED STATES - prnewswire.com","headline":"PADAGIS ANNOUNCES THE FIRST LAUNCH OF AN OVER-THE-COUNTER NALOXONE NASAL SPRAY IN THE UNITED STATES","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxPa2c2MExGYjZ1ZXlTV1drZDhEQVdBc0YwbE1KTHM3c2RmSy1TWHpXNnVOTUpTZENfWklxb1FrZ1U3dWd3OWt5ajJqY2FXeUs1UTU1N1BDSzZrdGZNcGZzQmhMMjVLMlVDcmw2b0N6bHJKVHlWcmVrZ1paeEkyMmxFMUp2bjRFN2JBMDVob0hyVDhJTmJlM2dFQ2RUV212T1hzMUlLQXJnVE00ZS1rNUw4QkZqQmNyamxHME9CQUs1QzdCdFpFcmUwcmV1SEp1UzVxTUtfenpYNA?oc=5","date":"2023-07-20","type":"pipeline","source":"prnewswire.com","summary":"PADAGIS ANNOUNCES THE ACQUISITION OF 17,000 SQUARE METER FACILITY IN YERUCHAM, ISRAEL - prnewswire.com","headline":"PADAGIS ANNOUNCES THE ACQUISITION OF 17,000 SQUARE METER FACILITY IN YERUCHAM, ISRAEL","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxNcXpCUlVVbjRzT1NXc2VQenFLQ0M4dlBhcVI0dHZ4Q25Wd1lxZ2dIOEItREdYeFVrQWlnaFUtTG1vOHJORjNlcm5vUFRsNU8xWXZVTG9weHJPSFhnUjUwa1dJM08yVzJiMXM0R0NCNHJrVUdoWmxPaV9IbEhHNGp2OE5EcTZoVHk1SVFtX0tHTzVHQ0ZrVE1VM2hybzc0cndyU0pySm9uRnlrWUpWaUpPdHBFWndwSEZ5U1lrN0R3QW01MVRpd1NMWnU0SVRMWTQ?oc=5","date":"2023-01-05","type":"regulatory","source":"Marijuana Moment","summary":"Pharma Company Behind FDA-Approved CBD Drug Sues A Dozen Competitors Over Alleged Patent Infringement - Marijuana Moment","headline":"Pharma Company Behind FDA-Approved CBD Drug Sues A Dozen Competitors Over Alleged Patent Infringement","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxOdzBNOWpqWlJPWDJPQzZ0ZHdnT0ZZanU1WUpHbmdiMHBaWkJFbmVmRkRrZ1FvaXdDTTVma2gxNW4yVU1sbktSekROMXJFY1dEUHZmQkhMdXJkLTJBOFNWUE5KNENVcEZLejdjakI3RUduZEFrM3hJN3U4NTYtWmxvM1Z1ck1qV3UxVC1zRWU4ME1qUG1VZVJ5QTVvUld1TjBS?oc=5","date":"2022-10-31","type":"pipeline","source":"Bloomberg Law News","summary":"Alcon Sues Padagis to Block Copies of Simbrinza Eye Drops (1) - Bloomberg Law News","headline":"Alcon Sues Padagis to Block Copies of Simbrinza Eye Drops (1)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxPVXlLYlNITjhzLTlGMkZkdUJCaDFnU1p2QjJ3TFJLalNmckhmOUpaZVhFd0wwQ01xZFMtaXNWVEh6Tl9ZNjFjTG13Q0kxb2w1Z2g0aFhsRUNNa0d6c1BiY3o2R0E0c2JncjZ4UkZ6M3FFbFRsMUwwaDJKWHFCM3BxeW91NVMwaENHRXhMbEplRm9CQ3pFZThDMkM0ZTFYdWNCVjJmUA?oc=5","date":"2022-06-21","type":"pipeline","source":"prnewswire.com","summary":"PADAGIS ANNOUNCES THREE MAJOR PRODUCT LAUNCHES - prnewswire.com","headline":"PADAGIS ANNOUNCES THREE MAJOR PRODUCT LAUNCHES","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxPcnRZb2dteUFCNzZVUm8yczhHTXhYNi03b1hDYmRzdjh5UDRnS1cyeHF0UkVaMDlWd1RTZF96X2xJMkIwTXhRZFB3eG5UV19CUW1fRlBTTURoc0NZNmJENWpYdkw3MDE5ZjZ5cmxQZjZqR2JfOTJLTDRIVnFBM0RjWUxlT3lFV0g3WUxrSURxVG9UcDNsMkNtNEMxNkZNa3p2N29zRHZ2RzlZcWxiWFNn?oc=5","date":"2021-07-07","type":"pipeline","source":"ArentFox Schiff","summary":"Schiff Counsels Altaris on its $1.55B Acquisition of Padagis - ArentFox Schiff","headline":"Schiff Counsels Altaris on its $1.55B Acquisition of Padagis","sentiment":"neutral"}],"patents":[],"drugCount":14,"phaseCounts":{"phase_3":10,"marketed":3,"phase_2":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}